EIDS Data Exchange Platform

EIDS DxP AREA OF INTEREST (AOI) #02

Data Exchange Services Operations, Modernization, and Development Published Under: Commercial Solutions Opening (CSO) HT003826SC005 Parameter

Details

Sponsoring
Agency

Defense Health Agency (DHA), Portfolio Acquisition Executive, Medical Digital Solutions (PAE MDS), Enterprise Intelligence & Data Solutions (EIDS) Program Management Office (PMO)

Notice Type

Area of Interest (AOI) Solicitation

Response
Phase

Phase I – Written Technical Solution Brief

Phase I
Question
Deadline

14 October 2026, 1400, Eastern Time

Phase I
Submission
Deadline

28 October 2026, 1400, Eastern Time

Review
Window

28 October – 13 November 2026

Award
Pathway

The Government will use Phase I and, if conducted, subsequent-phase responses to assess commercial feasibility, technical merit, technology readiness, cost-effectiveness, and the extent of any required testing, evaluation, integration, or modification. Based on that assessment and subject to applicable authorities, the Government may pursue a FARbased contract, a prototype other transaction agreement, or another authorized instrument. The Government is not committing to a particular award instrument, period of performance, or number of awards through this AOI. The Government anticipates a Firm-Fixed-Price pricing structure for any resulting award.

Authority

This AOI is issued under the DHA Enterprise-Wide Commercial Solutions Opening (CSO) HT003826SC005 pursuant to 10 U.S.C. § 3458, as amended. The Government may use any applicable award authority

Parameter

Details
identified in the CSO, consistent with the maturity and nature of the selected commercial solution and applicable law.

The Government anticipates making any resulting award or agreement by March 2027, subject to the completion of the evaluation process, Anticipated
availability of funds, selection of the appropriate acquisition pathway and Time to Award
applicable approvals. This is an estimate only and does not obligate the Government to make an award.
Notice: DHA reserves the right to award one or multiple contracts or agreements under this AOI. This solicitation leverages the competitive process under CSO HT003826SC005. Vendors must submit proposed solutions in accordance with the submission instructions and requirements contained herein. If a conflict exists between CSO HT003826SC005 and this EIDS DxP AOI, this EIDS DxP AOI shall prevail.

1.0 Executive Summary & Strategic Context

The Defense Health Agency (DHA), Portfolio Acquisition Executive Medical Digital Solutions